Rachel Gibson

Professor Rachel Gibson is a Professor and Head of School in the Allied Health Administration at the University of Adelaide. Her work focuses on gastrointestinal toxicity, chemotherapy-induced adverse effects, and microbiome interactions with diet and health. She leads research in mucositis management, drug delivery systems, and nutritional pathways in oncology care.

Her research interests include the gut microbiome's role in chemotherapy toxicity, mechanisms of gastrointestinal damage, and translational applications of intestine-on-chip models. She has contributed to international clinical guidelines on mucositis assessment and palliative care innovations during the pandemic.

Publications span 2016-2025, emphasizing chemotherapy-induced diarrhea, microbiome-drug interactions, and dietary interventions. She has pioneered digital health solutions for nutrition support and explored genetic predictors of adverse drug reactions. Current efforts address pain management in pediatric cerebral palsy and optimizing supportive cancer care pathways.

Grants and collaborations involve multidisciplinary teams in oncology, bioengineering, and public health. She advises on translational research bridging basic science to clinical practice, with a focus on improving patient outcomes through personalized interventions.